HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
SPV 30
an extract of the European boxwood tree from Arkopharma
Also Known As:
SPV-30
Networked:
2
relevant articles (
0
outcomes,
0
trials/studies)
Bio-Agent Context: Research Results
Complex Mixtures: 1906
Biological Products
Plant Preparations: 622
Plant Extracts: 3916
SPV 30: 2
Pharmaceutical Preparations
Plant Extracts: 3916
SPV 30: 2
Eukaryota
Viridiplantae
Streptophyta
Embryophyta
Tracheophyta
Magnoliopsida
Buxaceae
Buxus
SPV 30: 2
Related Diseases
1.
Disease Progression
03/01/1998 - "
The treatment groups differed statistically in the rate of disease progression also in favor of SPV(30) 990 mg/d.
"
2.
Fatigue
07/01/1995 - "
However, the publicity fact sheet states that preliminary data suggest that SPV-30 increases CD4 counts in participants, reduces fatigue, and improves the sense of well-being.
"
3.
AIDS-Related Complex (ARC)
03/01/1998 - "
There was a statistically significant difference in therapeutic failures between groups in favor of SPV(30) 990 mg including decreases of CD4 cell count < 200 × 10(6)/1 and/or number of clinical aggravations (progression to AIDS or AIDS related complex).
"
4.
Acquired Immunodeficiency Syndrome (AIDS)
03/01/1998 - "
There was a statistically significant difference in therapeutic failures between groups in favor of SPV(30) 990 mg including decreases of CD4 cell count < 200 × 10(6)/1 and/or number of clinical aggravations (progression to AIDS or AIDS related complex).
"